Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Lisdexamfetamine 50mg capsules
0404000U0AAADAD
|
Lisdexamfetamine | Lisdexamfetamine dimesylate | Central Nervous System | 23,446 |
|
Lisdexamfetamine 30mg capsules
0404000U0AAABAB
|
Lisdexamfetamine | Lisdexamfetamine dimesylate | Central Nervous System | 18,473 |
|
Lisdexamfetamine 70mg capsules
0404000U0AAAFAF
|
Lisdexamfetamine | Lisdexamfetamine dimesylate | Central Nervous System | 14,966 |
|
Lisdexamfetamine 40mg capsules
0404000U0AAACAC
|
Lisdexamfetamine | Lisdexamfetamine dimesylate | Central Nervous System | 13,371 |
|
Lisdexamfetamine 20mg capsules
0404000U0AAAAAA
|
Lisdexamfetamine | Lisdexamfetamine dimesylate | Central Nervous System | 9,892 |
|
Lisdexamfetamine 60mg capsules
0404000U0AAAEAE
|
Lisdexamfetamine | Lisdexamfetamine dimesylate | Central Nervous System | 8,343 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.